Correlation of clinical, laboratory, and short‐term outcomes of immunocompromised and immunocompetent COVID‐19 patients with semi‐quantitative chest CT score findings: A case‐control study

Abdolkarim Haji Ghadery,Ladan Abbasian,Fatemeh Jafari,Niloofar Ayoobi Yazdi,Zahra Ahmadinejad
DOI: https://doi.org/10.1002/iid3.1239
2024-04-07
Immunity Inflammation and Disease
Abstract:Background As the effects of immunosuppression are not still clear on COVID‐19 patients, we conducted this study to identify clinical and laboratory findings associated with pulmonary involvement in both immunocompromised and immunocompetent patients. Methods A case‐control of 107 immunocompromised and 107 immunocompetent COVID‐19 patients matched for age and sex with either positive RT‐PCR or clinical‐radiological findings suggestive of COVID‐19 enrolled in the study. Their initial clinical features, laboratory findings, chest CT scans, and short‐term outcomes (hospitalization time and intensive care unit [ICU] admission) were recorded. In addition, pulmonary involvement was assessed with the semi‐quantitative scoring system (0−25). Results Pulmonary involvement was significantly lower in immunocompromised patients in contrast to immunocompetent patients, especially in RLL (p = 0.001), LUL (p = 0.023), and both central and peripheral (p = 0.002), and peribronchovascular (p = 0.004) sites of lungs. Patchy (p
immunology
What problem does this paper attempt to address?